Physicians’ attitude towards selection of second line therapy with nilotinib and dasatinib in chronic myeloid leukemia patients

We investigated factors that physicians consider of most importance in the selection of second line tyrosine kinase inhibitors treatments (TKIs) in chronic myeloid leukemia patients (CML). ELECTRONIC SUPPLEMENTARY MATERIAL: The online version of this article (10.1186/s12955-017-0788-4) contains supp...

Полное описание

Сохранить в:
Библиографические подробности
Опубликовано в: :Health Qual Life Outcomes
Главные авторы: Breccia, Massimo, Baccarani, Michele, Rosti, Gianantonio, Cottone, Francesco, Cannella, Laura, Guilhot, François, Vignetti, Marco, Efficace, Fabio
Формат: Artigo
Язык:Inglês
Опубликовано: BioMed Central 2017
Предметы:
Letter to the Editor
Online-ссылка:https://ncbi.nlm.nih.gov/pmc/articles/PMC5648464/
https://ncbi.nlm.nih.gov/pubmed/29047379
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s12955-017-0788-4
Метки: Добавить метку
Нет меток, Требуется 1-ая метка записи!

Схожие документы